Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Haemonetics (HAE) Receivables - Net (2016 - 2025)

Haemonetics (HAE) has 16 years of Receivables - Net data on record, last reported at $195.7 million in Q4 2025.

  • For Q4 2025, Receivables - Net fell 7.66% year-over-year to $195.7 million; the TTM value through Dec 2025 reached $195.7 million, down 7.66%, while the annual FY2025 figure was $202.7 million, 1.89% down from the prior year.
  • Receivables - Net reached $195.7 million in Q4 2025 per HAE's latest filing, down from $207.1 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $213.5 million in Q3 2024 and bottomed at $127.6 million in Q2 2021.
  • Average Receivables - Net over 5 years is $179.9 million, with a median of $180.1 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: dropped 22.79% in 2021, then increased 24.95% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $141.3 million in 2021, then increased by 28.16% to $181.1 million in 2022, then grew by 16.85% to $211.6 million in 2023, then rose by 0.16% to $211.9 million in 2024, then decreased by 7.66% to $195.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $195.7 million in Q4 2025, $207.1 million in Q3 2025, and $200.8 million in Q2 2025.